Replies to post #11333 on Muscle Pharm Corporation (MSLPQ)

[Odessa99]

Justlovethegame, it may surprise you that I actually agree with your statement below. They are going about the financing all wrong. When the stock is in the toilet, as MSLP is, you sell no more than is absolutely necessary to survive. I do believe they should still be focused on extreme growth at the moment, and that will require funding. But the way I would go about getting that funding is to have Michael Vick, Chad Ochocinco, or one of the other pro sports millionaires gather a group of friends (potential investors) in the NFL, and convince one or several to acquire a trading-restricted percentage of Muscle Pharm for a sizable one-time check. Brad and Cory would likely have to agree to specific operational terms to protect that investors investment, but the upside for Brad, Cory and we shareholders would be an end to the extreme dilution at rock-bottom share prices, which may breathe new life into the MSLP share price. When the potential investor asks why they should consider investing in Muscle Pharm at an above market share price, they should simply explain that to try and buy a sizable stake in Muscle Pharm on the open market would quickly raise the share price to a cost prohibitive level. Once buying floods in, the old low price vanishes quickly like a thief in the night.

The problem is the stock price. It has crashed and burned even with sequential revenue growth. This causes these "relative" losses to
deplete a company of its most precious currency its shares. MSLP just sold 42 million shares for 375k. That is .00892 cents a share. Even at .025 they would have raised about a million.

[Bulldog2]

Justlovethegame, MP needs to show earnings next year. Revenue growth will slow, that is a fact. And that is not a sign of weakness. The Company can not sustain a 350% revenue growth. The international expansion will help, but revenue growth will slow.

I agree dilution is significant when you are trading at a penny. That is why management needs to communicate with investors, slow spending, and cut out crap like the bonus plan. They are killing the current shareholders.

I think we will see even greater dilution next year. MP is a cool company, but not a great investment right now.